Study: NCT03725384

Adverse event: Constipation
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using adverse effect questionnaire.
Frequency: 6 affected / 27 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 7 affected / 27 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Adverse effect reported at Week 4 using questionnaire
Frequency: 7 affected / 27 at risk

Adverse event: Dyspnoea
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 7 affected / 27 at risk

Adverse event: Dyspepsia
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 8 affected / 27 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 5 affected / 27 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 5 affected / 27 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 3 affected / 27 at risk

Adverse event: Constipation
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using adverse effect questionnaire.
Frequency: 6 affected / 24 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 4 affected / 24 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Adverse effect reported at Week 4 using questionnaire
Frequency: 4 affected / 24 at risk

Adverse event: Dyspnoea
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 4 affected / 24 at risk

Adverse event: Dyspepsia
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 2 affected / 24 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 2 affected / 24 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 2 affected / 24 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 1 affected / 24 at risk

Adverse event: Constipation
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using adverse effect questionnaire.
Frequency: 12 affected / 51 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 11 affected / 51 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Adverse effect reported at Week 4 using questionnaire
Frequency: 11 affected / 51 at risk

Adverse event: Dyspnoea
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 11 affected / 51 at risk

Adverse event: Dyspepsia
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 10 affected / 51 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 7 affected / 51 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 7 affected / 51 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Adverse effect reported at week 4 using questionnaire
Frequency: 4 affected / 51 at risk